• Sonuç bulunamadı

A-IX Editorial

N/A
N/A
Protected

Academic year: 2021

Share "A-IX Editorial"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Anatol J Cardiol, Vol: 21, Supplement: 1, March 2019

Editorial

Address for correspondence: Yüksel Çavuşoğlu, MD, FESC, Department of Cardiology, Faculty of Medicine, Eskişehir Osmangazi University, 26480, Eskişehir-Turkey

Phone: +90 222 239 29 79 E-mail: yukselc@ogu.edu.tr

©Copyright 2018 by Turkish Society of Cardiology - Available online at www.anatoljcardiol.com DOI:10.14744/AnatolJCardiol.2019.54789

Dear friends and colleagues,

Natriuretic peptides are currently widely used biomarkers and provide useful information in the diagnosis, prognosis and risk stratification in heart failure. These biomarkers are not only used in the management of heart failure, but also natriuretic peptides are referred to have potential role in pulmonary arterial hypertension, cardio-oncology, advanced heart failure, as-sessment of response to cardiac resynchronization therapy, acute coronary syndromes, atrial fibrillation and valvular heart disease. In this paper, updated information and new recommen-dations on natriuretic peptides in heart failure and also potential role of these biomarkers in the management of various clinical conditions have been addressed in the form of expert opinions based on the available data in the literature.

The present work as an initiative of Heart Failure Working Group of Turkish Society of Cardiology was written by the authors who have a broad range of expertise and experience in the field of heart failure, pulmonary arterial hypertension, arrhythmia, cardio-oncology, acute coronary syndromes and valvular heart diseases. This document is mainly focused on the clinical use of natriuretic peptides and intended for cardiologists, internists, cardiology trainees, general practitioners and nurses.

We hope you find this document helpful in clinical use of natriuretic peptides in your daily clinical practice.

Prof. Dr. Yüksel Çavuşoğlu, Fellow of the HFA, Fellow of the ESC Special Issue Editor

Former Chairperson of TSC Heart Failure Working Group (2012-2014 and 2017-2018) Eskişehir Osmangazi University, Faculty of Medicine, Cardiology Department, Eskişehir

Referanslar

Benzer Belgeler

This is due to various obstacles including the lack of PAUD administering institutions, the number of teaching staff both in terms of quantity and quality,

The power capacity of the hybrid diesel-solar PV microgrid will suffice the power demand of Tablas Island until 2021only based on forecast data considering the

As in the expression data processing done in PAMOGK we generated separate graph kernels for amplifications and deletions to not lose information provided by type of variation [6]..

Conclusion: Doppler echocardiography is an easy, non-invasive, and inexpensive method for measuring pulmonary arterial elastance, which provides accurate and reliable estimation of

Baseline six-minute walk distance (before treatment) Among patients treated with epoprostenol for 12 weeks, significantly lower baseline 6MWD was reported in 8 patients who died

Balloon pulmonary angioplasty has been considered an emerging treatment modality in small, segmental, and sub-segmental vessels in high-risk surgical patients due to

[r]

In addition, we suggest that the patients in the placebo group should also receive tertiary butylhydroquinone and tocopherols as they did in the 3 fatty acids group, to avoid